SCHEMBL23705000

SCHEMBL23705000

COCCOCCOCCOCCNCCCOCCNCCCOCCOCCC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 7/20 0.45
KDM4E B2RXH2 13/20 0.42
LMNA P02545 2/20 0.42
TSHR P16473 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
RECQL P46063 1/20 0.36
LTA4H P09960 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30018345 0.89 ALDH1A1 (0.55) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL26981157 0.88 ALDH1A1 (0.53) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL31584318 0.88 ALDH1A1 (0.42) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL14725908 0.87 ALDH1A1 (0.56) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL30103368 0.87 SMN1; SMN2 (0.46) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL18244688 0.86 ALDH1A1 (0.44) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL17822795 0.86 ALDH1A1 (0.44) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL31631006 0.85 ALDH1A1 (0.55) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL26689658 0.84 KDM4A (0.39) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL17229458 0.84 SMN1; SMN2 (0.38) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4097138-A1 ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS Avila Therapeutics, Inc. (US) 2022-12-07 EP disclosed
WO-2021155317-A1 ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS AVILAR THERAPEUTICS, INC. (US) 2021-08-05 WO disclosed